Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer

被引：0
|
作者：
Zhao, Ruiying [1 ]
Xiang, Chan [1 ]
Zhu, Lei [1 ]
Shao, Jinchen [1 ]
Zhao, Jikai [1 ]
Guo, Lianying [1 ]
Ma, Shengji [1 ]
Yu, Anbo [1 ]
Han, Yuchen
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1977
引用
收藏
页码：1833 / 1834
页数：2
相关论文
共 50 条
  • [21] Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations
    Fan, Yun
    Qiu, Jinrong
    Yu, Ruoying
    Cao, Ran
    Chen, Xiaoxi
    Ou, Qiuxiang
    Wu, Xue
    Shao, Yang W.
    Nagasaka, Misako
    Zhang, Jiexia
    Ou, Sai-Hong Ignatius
    [J]. MOLECULAR ONCOLOGY, 2020, 14 (08) : 1731 - 1739
  • [22] Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
    Rosell, Rafael
    Aguilar-Hernandez, Andres
    Gonzalez-Cao, Maria
    [J]. CANCERS, 2023, 15 (09)
  • [23] Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
    Wang, Jun
    Wang, Baocheng
    Chu, Huili
    Yao, Yunfeng
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 3711 - 3726
  • [24] EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications
    Yasuda, Hiroyuki
    Kobayashi, Susumu
    Costa, Daniel B.
    [J]. LANCET ONCOLOGY, 2012, 13 (01): : E23 - E31
  • [25] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
    Hou, Jiabao
    Li, Hongle
    Ma, Shuxiang
    He, Zhen
    Yang, Sen
    Hao, Lidan
    Zhou, Hanqiong
    Zhang, Zhe
    Han, Jing
    Wang, Li
    Wang, Qiming
    [J]. BIOMARKER RESEARCH, 2022, 10 (01)
  • [26] Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Daigo, Yataro
    Ito, Hiroyuki
    Isaka, Tetsuya
    Imai, Kentaro
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Matsukuma, Shoichi
    Tsuboi, Masahiro
    Nakayama, Haruhiko
    Masuda, Munetaka
    [J]. BMC CANCER, 2014, 14
  • [27] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
    Jiabao Hou
    Hongle Li
    Shuxiang Ma
    Zhen He
    Sen Yang
    Lidan Hao
    Hanqiong Zhou
    Zhe Zhang
    Jing Han
    Li Wang
    Qiming Wang
    [J]. Biomarker Research, 10
  • [28] PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers
    Jin, Guang
    Kim, Min Jung
    Jeon, Hyo-Sung
    Choi, Jin Eun
    Kim, Dong Sun
    Lee, Eung Bae
    Cha, Sung Ick
    Yoon, Ghil Sook
    Kim, Chang Ho
    Jung, Tae Hoon
    Park, Jae Yong
    [J]. LUNG CANCER, 2010, 69 (03) : 279 - 283
  • [29] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Yao, Yu
    Yang, Huaping
    Zhu, Bo
    Wang, Song
    Pang, Jiaohui
    Wu, Xiaoying
    Xu, Yang
    Zhang, Junli
    Zhang, Jinfeng
    Ou, Qiuxiang
    Tian, Hui
    Zhao, Zheng
    [J]. RESPIRATORY RESEARCH, 2023, 24 (01)
  • [30] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Yu Yao
    Huaping Yang
    Bo Zhu
    Song Wang
    Jiaohui Pang
    Xiaoying Wu
    Yang Xu
    Junli Zhang
    Jinfeng Zhang
    Qiuxiang Ou
    Hui Tian
    Zheng Zhao
    [J]. Respiratory Research, 24
12345